Aurobindo Pharma up 1%; gets USFDA nod for Eptifibatide Injection
The company has announced that it has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Eptifibatide Injection USP, 20 mg/10 mL, 75 mg/100 mL, and 200 mg/100 mL single-use vials.